Market Research Logo

Biopsy Device Market: Needles Product Type Segment Anticipated to Retain Its Dominance Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026

Biopsy Device Market: Needles Product Type Segment Anticipated to Retain Its Dominance Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026

Government initiatives in cancer treatment to fuel growth of the global biopsy device market during the projected period

Global demand for biopsy devices is increasing, supported by rising incidence of cancer. Future Market Insights presents in-depth analysis of the global biopsy device market for the forecast period, 2016–2026. Revenue from the global biopsy device market is expected to register a CAGR of 6.5% during the assessment period and is expected to be valued at nearly US$ 2,700 Mn by 2026 end.

Increasing incidence of cancer and favourable reimbursement programs are factors expected to drive revenue growth of the global biopsy device market during the assessment period

The guidance system segment was estimated to account for 16.1% revenue share of the global biopsy device market by 2016 end and is expected to gain 222 BPS in market share by 2026 over 2016, owing to an increase in the awareness of early detection of breast cancer.

The needles segment was estimated to account for 37.6% revenue share of the global biopsy device market by 2016 end and is expected to lose 125 BPS in market share by 2026 over 2016. The segment is expected to reach nearly US$ 960 Mn by 2026 owing to an increasing awareness among people regarding the early detection of cancer.

Global Biopsy Device Market Absolute $ Opportunity by Product Type, 2016–2026

Guidance system segment is estimated to create absolute $ opportunity of more than US$ 15 Mn in 2017 over 2016. Revenue from guidance system segment is anticipated to register a CAGR of 7.9% over 2016–2026, to reach more than US$ 480 Mn towards the close of the forecast period

Biopsy needles segment is estimated to create absolute $ opportunity of nearly US$ 30 Mn in 2017 over 2016. Revenue from biopsy needles segment is anticipated to register a CAGR of 6.2% over 2016–2026, to reach nearly US$ 960 Mn by 2026 end

Guns segment is estimated to create absolute $ opportunity of nearly US$ 25 Mn in 2017 over 2016. Revenue from guns segment is anticipated to witness a CAGR of 6.8% over 2016–2026, to reach more than US$ 700 Mn towards the close of 2026

Reagents and kits segment is estimated to create absolute $ opportunity of more than US$ 3 Mn in 2017 over 2016. Revenue from reagents and kits segment is anticipated to witness a CAGR of 6.4% over 2016–2026, to reach nearly US$ 120 Mn at the end of the assessment period

Others (Brushes, Curettes and Punches etc.) segment is estimated to create absolute $ opportunity of nearly US$ 10 Mn in 2017 over 2016. Revenue from Others segment is anticipated to witness a CAGR of 5.3% over 2016–2026, to reach more than US$ 360 Mn by 2026 end

Global Biopsy Device Market Attractiveness Analysis by Product Type, 2016–2026

Needles segment dominated the global biopsy device market in revenue terms in 2015 and is projected to continue to do so throughout the forecast period. Needles segment is the most attractive segment, with a market attractiveness index of 1.8 over the forecast period. The segment accounted for 37.7% value share in 2016 and is projected to account for 36.5% share by 2026 end. Guns segment is expected to be the second most lucrative segment in the global biopsy device market, with a market attractiveness index of 1.3 during the forecast period. The increasing requirement for more advanced and innovative technology products in the field of biopsy and growing usage of biopsy needles makes it the most attractive segment in the global biopsy device market. Companies operating in the global biopsy device market are actively engaged in mergers, acquisitions and partnerships to capture a larger share of the market in the near future

The global biopsy device market is a fragmented market with about 69% market share contributed by CR Bard, Becton, Dickinson and Company, B. Braun Melsungen AG, Hologic, Inc., Cook Medical, Devicor Medical Products Inc. and Argon Medical Inc. Companies are entering into strategic mergers and acquisitions to improve their biopsy device product portfolio and are focussing on distributional agreements to overcome issues related to product availability in various geographical areas.

Analyst Viewpoint

“In the coming decade, liquid biopsy procedure is likely to pose a major threat to the biopsy device market”

Liquid biopsy offers non-invasive diagnostic tests for detecting cancer as it provides a simple, relatively less expensive blood, urine or plasma test to detect malignancy in any part of the patient’s body. Liquid biopsy is expected to provide a better sample for any type of diagnosis and analysis as it can be taken repeatedly. This overcomes the challenge associated with repeated tissue samples. Liquid samples help detect disease progression in real time, predict outcomes and switch treatment when required and potentially increase the life expectancy of the patient. Thus, liquid biopsy procedure is likely to be a major threat to the global biopsy device market in the coming decade.


1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
2.3. Parent / Associated Market Overview
3. Global Biopsy Device Analysis Scenario
3.1. Pricing Analysis
3.1.1. Pricing Assumptions
3.1.2. Price Projections Per Region
3.2. Market Size (US$ Mn) and Forecast
3.2.1. Market Size and Y-o-Y Growth
3.2.2. Absolute $ Opportunity
3.3. Market Overview
3.3.1. Value Chain
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Forecast Factors – Relevance and Impact
4.6. Global Incidence of Cancer
4.7. Global Trends
5. Global Biopsy Device Analysis and Forecasts, By Product
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Product Type
5.3. Y-o-Y Growth Projections By Product Type
5.4. Market Value and Volume Forecast By Product, 2016–2026
5.4.1. Guidance System
5.4.1.1. Stereotactic X-Ray Guided Biopsy
5.4.1.2. Ultrasound Guided Biopsy
5.4.1.3. MRI Guided Biopsy
5.4.2. Needles
5.4.2.1. Core Needle
5.4.2.2. Fine Aspiration Needles
5.4.3. Guns
5.4.4. Reagents and Kits
5.4.5. Others (Brushes, Curettes and Punches etc.)
5.5. Market Attractiveness By Product
6. Global Biopsy Device Analysis and Forecasts, By Application
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Application
6.3. Y-o-Y Growth Projections By Application
6.4. Market Value Forecast By Application, 2016–2026
6.4.1. Scientific Research
6.4.2. Medical Diagnostics
6.5. Market Attractiveness By Application
7. Global Biopsy Device Analysis and Forecasts, By End Users
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By End Users
7.3. Y-o-Y Growth Projections By End Users
7.4. Market Value Forecast By End Users, 2016–2026
7.4.1. Hospitals
7.4.2. Specialized Oncology Centers
7.4.3. Diagnostic Centers
7.4.4. Research Institutes
7.5. Market Attractiveness By End Users
8. Global Biopsy Device Analysis and Forecasts, By Region
8.1. Basis Point Share (BPS) Analysis By Region
8.2. Y-o-Y Growth Projections By Region
8.3. Market Value Forecast By Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. APEJ
8.3.6. Japan
8.3.7. MEA
8.4. Market Attractiveness By Region
9. North America Biopsy Device Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.1.3. Key Regulations
9.2. Market Value and Volume Forecast By Product, 2016–2026
9.2.1. Guidance System
9.2.1.1. Stereotactic X-Ray Guided Biopsy
9.2.1.2. Ultrasound Guided Biopsy
9.2.1.3. MRI Guided Biopsy
9.2.2. Needles
9.2.2.1. Core Needle
9.2.2.2. Fine Aspiration Needles
9.2.3. Guns
9.2.4. Reagents and Kits
9.2.5. Others (Brushes, Curettes and Punches etc.)
9.3. Market Value Forecast By Application, 2016–2026
9.3.1. Scientific Research
9.3.2. Medical Diagnostics
9.4. Market Value Forecast By End Users, 2016–2026
9.4.1. Hospitals
9.4.2. Specialized Oncology Centers
9.4.3. Diagnostic Centers
9.4.4. Research Institutes
9.5. Market Value Forecast By Country, 2016–2026
9.5.1. US
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By Application
9.6.3. By End Users
9.6.4. By Country
10. Latin America Biopsy Device Analysis and Forecast
10.1.Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.1.3. Key Regulations
10.2.Market Value and Volume Forecast By Product, 2016–2026
10.2.1. Guidance System
10.2.1.1. Stereotactic X-Ray Guided Biopsy
10.2.1.2. Ultrasound Guided Biopsy
10.2.1.3. MRI Guided Biopsy
10.2.2. Needles
10.2.2.1. Core Needle
10.2.2.2. Fine Aspiration Needles
10.2.3. Guns
10.2.4. Reagents and Kits
10.2.5. Others (Brushes, Curettes and Punches etc.)
10.3.Market Value Forecast By Application, 2016–2026
10.3.1. Scientific Research
10.3.2. Medical Diagnostics
10.4.Market Value Forecast By End Users, 2016–2026
10.4.1. Hospitals
10.4.2. Specialized Oncology Centers
10.4.3. Diagnostic Centers
10.4.4. Research Institutes
10.5.Market Value Forecast By Country, 2016–2026
10.5.1. Argentina
10.5.2. Brazil
10.5.3. Mexico
10.5.4. Rest of Latin America
10.6.Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End Users
10.6.4. By Country
11. Western Europe Biopsy Device Analysis and Forecast
11.1.Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.1.3. Key Regulations
11.2.Market Value and Volume Forecast By Product, 2016–2026
11.2.1. Guidance System
11.2.1.1. Stereotactic X-Ray Guided Biopsy
11.2.1.2. Ultrasound Guided Biopsy
11.2.1.3. MRI Guided Biopsy
11.2.2. Needles
11.2.2.1. Core Needle
11.2.2.2. Fine Aspiration Needles
11.2.3. Guns
11.2.4. Reagents and Kits
11.2.5. Others (Brushes, Curettes and Punches etc.)
11.3.Market Value Forecast By Application, 2016–2026
11.3.1. Scientific Research
11.3.2. Medical Diagnostics
11.4.Market Value Forecast By End Users, 2016–2026
11.4.1. Hospitals
11.4.2. Specialized Oncology Centers
11.4.3. Diagnostic Centers
11.4.4. Research Institutes
11.5.Market Value Forecast By Country, 2016–2026
11.5.1. UK
11.5.2. France
11.5.3. Germany
11.5.4. Italy
11.5.5. Spain
11.5.6. Nordic
11.5.7. Benelux
11.5.8. Rest of Western Europe
11.6.Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End Users
11.6.4. By Country
12. Eastern Europe Biopsy Device Analysis and Forecast
12.1.Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.1.3. Key Regulations
12.2.Market Value and Volume Forecast By Product, 2016–2026
12.2.1. Guidance System
12.2.1.1. Stereotactic X-Ray Guided Biopsy
12.2.1.2. Ultrasound Guided Biopsy
12.2.1.3. MRI Guided Biopsy
12.2.2. Needles
12.2.2.1. Core Needle
12.2.2.2. Fine Aspiration Needles
12.2.3. Guns
12.2.4. Reagents and Kits
12.2.5. Others (Brushes, Curettes and Punches etc.)
12.3.Market Value Forecast By Application, 2016–2026
12.3.1. Scientific Research
12.3.2. Medical Diagnostics
12.4.Market Value Forecast By End Users, 2016–2026
12.4.1. Hospitals
12.4.2. Specialized Oncology Centers
12.4.3. Diagnostic Centers
12.4.4. Research Institutes
12.5.Market Value Forecast By Country, 2016–2026
12.5.1. Russia
12.5.2. Poland
12.5.3. Rest of Eastern Europe
12.6.Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End Users
12.6.4. By Country
13. APEJ Biopsy Device Analysis and Forecast
13.1.Introduction
13.1.1. Basis Point Share (BPS) Analysis By Country
13.1.2. Y-o-Y Growth Projections By Country
13.1.3. Key Regulations
13.2.Market Value and Volume Forecast By Product, 2016–2026
13.2.1. Guidance System
13.2.1.1. Stereotactic X-Ray Guided Biopsy
13.2.1.2. Ultrasound Guided Biopsy
13.2.1.3. MRI Guided Biopsy
13.2.2. Needles
13.2.2.1. Core Needle
13.2.2.2. Fine Aspiration Needles
13.2.3. Guns
13.2.4. Reagents and Kits
13.2.5. Others (Brushes, Curettes and Punches etc.)
13.3.Market Value Forecast By Application, 2016–2026
13.3.1. Scientific Research
13.3.2. Medical Diagnostics
13.4.Market Value Forecast By End Users, 2016–2026
13.4.1. Hospitals
13.4.2. Specialized Oncology Centers
13.4.3. Diagnostic Centers
13.4.4. Research Institutes
13.5.Market Value Forecast By Country, 2016–2026
13.5.1. China
13.5.2. India
13.5.3. Australia & New Zealand
13.5.4. ASEAN
13.5.5. Rest of APEJ
13.6.Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End Users
13.6.4. By Country
14. Japan Biopsy Device Analysis and Forecast
14.1.Introduction
14.1.1. Basis Point Share (BPS) Analysis By Country
14.1.2. Y-o-Y Growth Projections By Country
14.1.3. Key Regulations
14.2.Market Value and Volume Forecast By Product, 2016–2026
14.2.1. Guidance System
14.2.1.1. Stereotactic X-Ray Guided Biopsy
14.2.1.2. Ultrasound Guided Biopsy
14.2.1.3. MRI Guided Biopsy
14.2.2. Needles
14.2.2.1. Core Needle
14.2.2.2. Fine Aspiration Needles
14.2.3. Guns
14.2.4. Reagents and Kits
14.2.5. Others (Brushes, Curettes and Punches etc.)
14.3.Market Value Forecast By Application, 2016–2026
14.3.1. Scientific Research
14.3.2. Medical Diagnostics
14.4.Market Value Forecast By End Users, 2016–2026
14.4.1. Hospitals
14.4.2. Specialized Oncology Centers
14.4.3. Diagnostic Centers
14.4.4. Research Institutes
14.5.Market Attractiveness Analysis
14.5.1. By Product
14.5.2. By Application
14.5.3. By End Users
15. MEA Biopsy Device Analysis and Forecast
15.1.Introduction
15.1.1. Basis Point Share (BPS) Analysis By Country
15.1.2. Y-o-Y Growth Projections By Country
15.1.3. Key Regulations
15.2.Market Value and Volume Forecast By Product, 2016–2026
15.2.1. Guidance System
15.2.1.1. Stereotactic X-Ray Guided Biopsy
15.2.1.2. Ultrasound Guided Biopsy
15.2.1.3. MRI Guided Biopsy
15.2.2. Needles
15.2.2.1. Core Needle
15.2.2.2. Fine Aspiration Needles
15.2.3. Guns
15.2.4. Reagents and Kits
15.2.5. Others (Brushes, Curettes and Punches etc.)
15.3.Market Value Forecast By Application, 2016–2026
15.3.1. Scientific Research
15.3.2. Medical Diagnostics
15.4.Market Value Forecast By End Users, 2016–2026
15.4.1. Hospitals
15.4.2. Specialized Oncology Centers
15.4.3. Diagnostic Centers
15.4.4. Research Institutes
15.5.Market Value Forecast By Country, 2016–2026
15.5.1. GCC Countries
15.5.2. South Africa
15.5.3. North Africa
15.5.4. Rest of MEA
15.6.Market Attractiveness Analysis
15.6.1. By Product
15.6.2. By Application
15.6.3. By End Users
15.6.4. By Country
16. Competition Landscape
16.1. Competition Dashboard
16.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
16.2.1. Becton, Dickinson and Company
16.2.2. Argon Medical Inc.
16.2.3. B. Braun Melsungen AG
16.2.4. Boston Scientific Inc.
16.2.5. C. R. Bard, Inc.
16.2.6. Hologic, Inc.
16.2.7. Cook Medical
16.2.8. INRAD Inc.
16.2.9. Devicor Medical Products Inc.
16.2.10. PLANMED OY

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report